Clinical Trial: Efficacy and Safety of AG2001 in Patients With Acute Bronchitis

U.S., Oct. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07198347) titled 'Efficacy and Safety of AG2001 in Patients With Acute Bronchitis' on Sept. 15.

Brief Summary: This is a Phase 3, randomized, double-blind, active-controlled clinical trial designed to evaluate the efficacy and safety of AG2001 in patients with acute bronchitis. The primary objective is to demonstrate the superiority of AG2001 over two active comparators based on the change in Bronchitis Severity Score (BSS) at Day 4.

Study Start Date: Nov. 01

Study Type: INTERVENTIONAL

Condition: Acute Bronchitis

Intervention: DRUG: AG2001

Oral administration, three times daily for 7 days.

DRUG: AG20011

Oral administration, three times daily ...